The use of remdesivir outside of clinical trials during the COVID-19 pandemic

Vesa Halimi1 Faculty of Pharmacy,University Ss. Cyril and Methodius University,Skopje,North Macedonia.

Armond Daci2 Department of Pharmacy, Faculty of Medicine,University of Prishtina,Prishtina,Kosovo.

Nevenka Ridova3 University Clinic of Hematology, Medical Faculty,University Ss. Cyril and Methodius University,Skopje,North Macedonia.

Irina Panovska-Stavridis3 University Clinic of Hematology, Medical Faculty,University Ss. Cyril and Methodius University,Skopje,North Macedonia.

Milena Stevanovic4 University Clinic of Infection Diseases and Febrile Conditions, Medical Faculty,University Ss. Cyril and Methodius,Skopje,North Macedonia.

Venko Filipce5 University Clinic for Neurosurgery, Medical Faculty,University Ss. Cyril and Methodius,Skopje,North Macedonia.

Aleksandar Dimovski1 Faculty of Pharmacy,University Ss. Cyril and Methodius University,Skopje,North Macedonia.

Aleksandra Grozdanova1 Faculty of Pharmacy,University Ss. Cyril and Methodius University,Skopje,North Macedonia.Correspondence[email protected]

https://orcid.org/0000-0002-0098-8691

show all

The use of remdesivir outside of clinical trials during the COVID-19 pandemic

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The use of remdesivir outside of clinical trials during the COVID-19 pandemic

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date